MDMB-4en-PINACA is classified as a synthetic cannabinoid. Synthetic cannabinoids have been reported to cause psychoactive effects similar to delta-9-tetrahydrocannabinol (THC). Synthetic cannabinoids have caused adverse events, including deaths, as described in the literature. 5F-MDMB-PINACA (5F-ADB) is a structurally similar synthetic cannabinoid and scheduled substance in the United States; MDMB-4en-PINACA is not explicitly scheduled. MDMB-4en-PINACA has been identified in two Indiana cases since the end of July 2019 in blood specimens collected as part of postmortem investigations.
Analytical data are contained in the attached document. Through this service, we are reporting novel compounds not previously reported in the NFLIS annual/semi-annual reports, or for which SWGDRUG has not yet issued a monograph. If reference standards are commercially available, their acquisition and analysis are indicated within the attached monograph. If no reference standard is available, identifications are made based on evaluation of data from testing by GC-MS, LC-HRMS (e.g. QTOF), and/or other analytical technique(s).
The opinions, findings, and conclusions or recommendations expressed in this publication, program, or exhibition are those of the author(s) and do not necessarily reflect those of the Department of Justice.
GENERAL INFORMATION IUPAC Name: Methyl 3,3-dimethyl-2-[(1-pent-4-enylindazole-3- carbonyl)amino]butanoate InChI String: InChI=1S/C20H27N3O3/c1-6-7-10-13-23-15-12-9-8-11- 14(15)16(22-23)18(24)21-17(19(25)26-5)20(2,3)4/h6,8-9,11- 12,17H,1,7,10,13H2,2-5H3,(H,21,24) CFR: Not Scheduled (09/2019) CAS# Not Available Synonyms: MDMB-PENINACA, MDMB-PINACA N1-pentyl-4-en isomer, 5-CL-ADB-A
MDMB-4en-PINACA is classified as a synthetic cannabinoid. Synthetic cannabinoids have been reported to cause psychoactive effects similar to delta-9-tetrahydrocannabinol (THC). Synthetic cannabinoids have caused adverse events, including deaths, as described in the literature. 5F-MDMB-PINACA (5F-ADB) is a structurally similar synthetic cannabinoid and scheduled substance in the United States; MDMB-4en-PINACA is not explicitly scheduled.
MDMB-4en-PINACA has been identified in two cases since the end of July 2019. The geographical and demographical breakdown is below: Geographical Location: Indiana (n=2) Case Type: Postmortem Investigation (n=2) Biological Sample: Blood (n=2) Date of First Collection: July 21, 2019 Date of First Receipt: July 23, 2019 Additional Cannabinoids: 5F-MDMB-PICA (n=1)